Adaptive Biotechnologies Insider Sold Shares Worth $1,014,329, According to a Recent SEC Filing

MT newswire2026/10/06 07:25

03:25 AM EDT, 10/06/2026 (MT Newswires) -- Julie Rubinstein, President and Chief Operating Officer, on October 01, 2026, sold 35,643 shares in Adaptive Biotechnologies (ADPT) for $1,014,329. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 377,802 common shares of the company, with 377,802 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178066426000035/xslF345X05/form4.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.